Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
PUT
iShares MSCI Canada ETF
EWC
$6.17B
| $181M | 0.08% |
+5,525,000
| New | +$183M |
|
177
Vertex Pharmaceuticals
VRTX
$122B
| $177M | 0.08% |
611,787
+198,887
| +48% | +$60.6M |
|
178
AutoZone
AZO
$49.1B
| $174M | 0.08% |
70,622
+14,912
| +27% | +$36M |
|
179
Biogen
BIIB
$30.7B
| $172M | 0.08% |
622,728
+286,871
| +85% | +$81M |
|
180
Mondelez International
MDLZ
$80.5B
| $172M | 0.08% |
2,579,789
+567,967
| +28% | +$35.9M |
|
|
FRC
181
DELISTED
First Republic Bank
FRC
| $172M | 0.08% |
1,408,845
+98,848
| +8% | +$12.1M |
|
182
PUT
3M
MMM
$90.8B
| $172M | 0.08% |
1,710,758
+1,626,799
| +1,938% | +$166M |
|
|
FISV
183
Fiserv Inc
FISV
$28.8B
| $170M | 0.08% |
1,679,907
+552,705
| +49% | +$55M |
|
184
Vanguard S&P 500 ETF
VOO
$972B
| $169M | 0.08% |
480,774
+13,694
| +3% | +$4.84M |
|
185
Phillips 66
PSX
$84.4B
| $167M | 0.07% |
1,602,217
-481,272
| -23% | -$49.2M |
|
186
Canadian Pacific Kansas City
CP
$78.3B
| $166M | 0.07% |
2,226,180
+2,033,408
| +1,055% | +$153M |
|
187
PUT
Advanced Micro Devices
AMD
$791B
| $165M | 0.07% |
+2,551,100
| New | +$168M |
|
188
PUT
Netflix
NFLX
$305B
| $165M | 0.07% |
+5,587,000
| New | +$157M |
|
189
Regeneron Pharmaceuticals
REGN
$77.4B
| $165M | 0.07% |
228,174
+72,348
| +46% | +$53.4M |
|
190
PUT
Palo Alto Networks
PANW
$265B
| $164M | 0.07% |
+2,357,400
| New | +$189M |
|
191
GE Aerospace
GE
$368B
| $164M | 0.07% |
3,145,401
+1,088,572
| +53% | +$53.5M |
|
192
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.5B
| $164M | 0.07% |
494,464
+422,442
| +587% | +$137M |
|
193
Micron Technology
MU
$988B
| $163M | 0.07% |
3,268,550
-458,086
| -12% | -$25.1M |
|
194
Ross Stores
ROST
$81B
| $163M | 0.07% |
1,406,551
+671,574
| +91% | +$68.5M |
|
195
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.49B
| $162M | 0.07% |
+2,765,000
| New | +$170M |
|
196
CALL
Moderna
MRNA
$23B
| $161M | 0.07% |
+896,800
| New | +$147M |
|
197
CALL
iShares MSCI Brazil ETF
EWZ
$9.25B
| $161M | 0.07% |
+5,745,000
| New | +$175M |
|
198
PUT
Morgan Stanley
MS
$330B
| $159M | 0.07% |
+1,873,600
| New | +$160M |
|
199
PUT
Amazon
AMZN
$2.53T
| $158M | 0.07% |
+1,883,500
| New | +$186M |
|
200
Newmont
NEM
$101B
| $155M | 0.07% |
3,275,728
-904,424
| -22% | -$40.4M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.